Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Dec. 31, 2012
Current assets    
Cash and cash equivalents $ 311,356 $ 370,776
Restricted cash 32,191 52,422
Accounts receivable, net of allowance for doubtful accounts of $6,520 (2012 — $7,899) 727,462 725,809
Rebates receivable 316,866 302,461
Other current assets 111,634 101,311
Total current assets 1,499,509 1,552,779
Property and equipment, net of accumulated depreciation of $72,151 (2012 — $64,048) 123,693 105,201
Goodwill 4,478,318 4,478,038
Other intangible assets, net of accumulated amortization of $210,409 (2012 — $178,188) 1,148,935 1,198,991
Other long-term assets 46,339 50,118
Total assets 7,296,794 7,385,127
Current liabilities    
Accounts payable 610,681 644,818
Accrued expenses and other current liabilities 250,100 254,811
Pharmacy benefit management rebates payable 292,526 302,065
Current portion - long-term debt 55,000 41,250
Total current liabilities 1,208,307 1,242,944
Deferred income taxes 340,452 344,232
Long-term debt 1,019,880 1,132,153
Other long-term liabilities 51,006 55,937
Total liabilities 2,619,645 2,775,266
Commitments and contingencies (Note 11)      
Shareholders’ equity    
Common shares: no par value, unlimited shares authorized; 205,905,384 shares issued and outstanding, March 31, 2013 (December 31, 2012 — 205,399,102 shares) 4,202,801 4,180,778
Additional paid-in capital 63,864 73,530
Retained earnings 406,399 354,991
Accumulated other comprehensive income (1,930) (2,191)
Total shareholders' equity 4,671,134 4,607,108
Non-controlling interest 6,015 2,753
Total equity 4,677,149 4,609,861
Total liabilities and equity $ 7,296,794 $ 7,385,127